[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"endoscopic-surgery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:endoscopic-surgery":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,42,79,106,129,157],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100618927","a-study-on-the-safety-and-effectiveness-of-endoscopic-intracavitary-submucosal-dissection-for-gastric-extracavitary-type-submucosal-tumors-100618927",false,"NCT07337980","A Study on the Safety and Effectiveness of Endoscopic Intracavitary Submucosal Dissection for Gastric Extracavitary-Type Submucosal Tumors","Inclusion Criteria:\n\n* (1) CT scan showed extramural protrusion of the stomach (2) ultrasonic endoscopy revealed submucosal tumors with extra-gastric growth; (3) patients received ESD\u002FEFTR or surgical treatment\n\nExclusion Criteria:\n\n* (1) patients had malignant tumors in the stomach or had undergone stomach surgery (2) follow-up records were incomplete.","ALL","18 Years","80 Years",{"count":19,"type":20},20,"ESTIMATED","12 Months","OBSERVATIONAL","The aim of this study is to explore the safety and efficacy of endoscopic surgery in the treatment of extraluminal growing stromal tumors",[25,26],"Interstitialoma","Endoscopic Surgery",[28,29],"endoscopic surgery","interstitialoma","NOT_YET_RECRUITING","2026-01-03",{"date":33,"type":34},"2026-01-13","ACTUAL",{"date":36,"type":20},"2026-01-01",{"date":38,"type":20},"2026-12-31",{"name":40,"class":41},"Zhongda Hospital","OTHER",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":64,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":78},"100593147","clinical-impact-of-surgical-wound-morbidity-according-to-the-type-of-saphenous-vein-harvesting-technique-endoscopic-vs-open-in-patients-undergoing-myocardial-revascularization-surgery-100593147","NCT07002658","Clinical Impact of Surgical Wound Morbidity According to the Type of Saphenous Vein Harvesting Technique (Endoscopic vs. Open) in Patients Undergoing Myocardial Revascularization Surgery","Endoscopic Saphenous Vein Harvesting Versus Conventional Open Harvesting in Patients Undergoing Coronary Artery Bypass Grafting, Either Alone or in Combination With Another Cardiac Surgical Procedure, in Terms of the Clinical Impact of Surgical Wound Morbidity","EndOSiC","Inclusion Criteria:\n\n* Patients undergoing coronary artery bypass grafting (CABG), alone or in combination with other surgery (valve or arrhythmia surgery), with or without cardiopulmonary bypass (CPB), in which preoperative evaluation includes the plan to use a short saphenous vein segment (alone or in addition to arterial conduits).\n* Availability of a surgeon or cardiac surgery resident trained in endoscopic harvesting in the operating room.\n* Patients undergoing myocardial revascularization surgeries with or without extracorporeal circulation.\n* Patients undergoing concomitant cardiac valve replacement surgery, atrial fibrillation surgery, and others, in addition to CABG\n\nExclusion Criteria:\n\n* Emergent surgery or procedures performed during cardiorespiratory arrest\n* Myocardial revascularization with arterial grafts only\n* Presence of varicose veins\n* History of infrainguinal vascular surgery\n* Presence of ulcers and\u002For active infection in the lower limbs\n* Previous stroke with neurological sequelae in the legs\n* History of deep vein thrombosis in the legs\n* Pregnancy\n* Age under 18 years\n* Lack of signed informed consent",{"count":51,"type":20},356,"INTERVENTIONAL",[54],"NA","The goal of this clinical trial is to compare two different techniques: endoscopic saphenous vein harvesting versus conventional open harvesting in patients undergoing coronary artery bypass grafting, either alone or in combination with another cardiac surgical procedure (valve surgery or arrhythmia surgery). The main questions the trial aims to answer are:\n\nDoes the endoscopic technique reduce surgical wound morbidity in terms of shorter hospital stays? Does endoscopic saphenous harvesting reduce the use of antibiotics for saphenectomy wound infections? Does the endoscopic technique reduce need for wound dressings due to necrosis and\u002For wound infection, and reduce need for analgesic treatment for wound pain? This prospective, randomized study will be conducted in the Cardiovascular Surgery Service at Hospital Clínico San Carlos.\n\nParticipants will be randomly assigned to a different saphenectomy technique. All patients will be assessed for saphenectomy wound complications upon discharge, and by phone call at 7 days, 1 month, and 3 months following the intervention.",[57,58,26,59,60,61,62,63],"CABG-patients","Saphenectomy","Wound Complications","Antibiotic Use","Cardiac Surgery","Off Pump Coronary Artery Bypass Graft","Coronary Artery Bypass Graft With or Without ECC",[65,66,67,68],"endoscopic vein harvesting","CABG surgery","open vein harvesting","wound morbidity","2025-06-03",{"date":71,"type":34},"2025-06-06",{"date":73,"type":20},"2025-07-01",{"date":75,"type":20},"2026-08-01",{"name":77,"class":41},"Hospital San Carlos, Madrid",1,{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":87,"minAge":4,"maxAge":4,"enrollmentInfo":88,"targetDuration":90,"studyType":22,"phases":4,"briefSummary":91,"conditions":92,"keywords":4,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":78},"100573622","endoscopic-and-robotic-nsm-with-immediate-prosthesis-breast-reconstruction-100573622","NCT06748677","Endoscopic and Robotic NSM with Immediate Prosthesis Breast Reconstruction","Prospective Cohort Study of Minimally Invasive Surgery Versus Traditional Open Surgery for Nipple Areola Preserving Mastectomy Combined with Immediate Prosthesis Reconstruction","EnRoNSM","Inclusion Criteria:\n\n1. Underwent surgical treatment at Peking University People's Hospital, with hospitalization records;\n2. Preoperative core needle biopsy confirmed breast cancer;\n3. The clinical stage of the tumor is stage 0-IIIB; 4）cT≤5cm， cN0\u002FcN1，M0， And there is no tumor invasion of the nipple areola complex, skin, and chest wall;\n\n5\\) Intraoperative plan to use non biological patches (such as TiLoop) to partially or completely wrap the prosthesis 6) Signed agreement to participate in this study; 7) Can cooperate to complete the Patient Reported Outcome Measures (PROMs) questionnaire.\n\nExclusion Criteria:\n\n1. Lack of clinical pathological data (such as imaging data, pathological data);\n2. Pregnancy or lactation period;\n3. Patients with metastatic breast cancer or bilateral breast cancer;\n4. Have undergone breast conserving surgery\u002Fchest radiation therapy before;\n5. Patients with nipple areola invasion and subsequent removal of nipple areola complex;\n6. Failed to undergo curative surgery;","FEMALE",{"count":89,"type":20},484,"5 Years","Breast cancer is the most common malignant tumor in women. Surgical treatment is the most important treatment for early breast cancer. Breast cancer resection is considered to be a destructive operation. Patients need to accept the double blow of physical and psychological loss of breast shape. Although with the change of the concept of early diagnosis and treatment of breast cancer, the breast conserving rate of breast cancer is gradually increasing in China, more than half of the patients are still unable to retain breast due to their condition. For these patients, breast reconstruction surgery is an important means to improve the postoperative breast shape. With the improvement of surgical technology, endoscopic\u002Frobotic NSM combined with immediate prosthesis breast reconstruction has been gradually developed. According to previous literature reports, it has good tumor safety and aesthetics, but it is still lack of large-scale prospective results.\n\nThis project plans to adopt a prospective cohort design, based on the large sample breast disease cohort database established by the breast center of Peking University People's Hospital, and prospectively include patients who receive NSM combined with immediate prosthesis reconstruction under endoscopy\u002Frobot and conventional surgery from January 1, 2025 to December 31, 2028. The perioperative complications, tumor safety and patient reported outcomes of the two methods were compared.",[93,94,26,95],"Nipple-sparing Mastectomy","Immediate Prosthesis Reconstruction","Robotic Surgery","RECRUITING","2025-01-05",{"date":99,"type":34},"2025-01-07",{"date":101,"type":34},"2025-01-03",{"date":103,"type":20},"2031-12-31",{"name":105,"class":41},"Peking University People's Hospital",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":52,"phases":117,"briefSummary":118,"conditions":119,"keywords":4,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":127,"locationsCount":78},"100546734","dual-port-trans-subclavian-thyroid-endoscopic-surgery-100546734","NCT06398795","Dual-port Trans-subclavian Thyroid Endoscopic Surgery","Dual-port Trans-subclavian Thyroid Endoscopic Surgery - an Exploration of Cavity Construction in Situ Heralds a New Approach Choice","DTS","Inclusion Criteria:\n\n* Thyroid cancer or benign thyroid tumors\n* Patients with a demand for incisional cosmetic improvement\n\nExclusion Criteria:\n\n* Patients with thyroid cancer larger than 2 cm\n* benign tumors larger than 5 cm\n* Patients with severe underlying diseases\n* Patients with chronic kidney disease,\n* Patients with autoimmune diseases\n* Patients with rheumatoid arthritis","90 Years",{"count":116,"type":20},300,[54],"This is a prospective, single-center, open-label, non-randomized controlled real-world study aimed at exploring a novel approach to cavity construction for thyroid endoscopic surgery. The study seeks to evaluate its effectiveness and safety while accumulating further evidence-based medical data.\n\nThree hundred patients with thyroid tumors were divided into an experimental group (150 cases receiving a new endoscopic thyroid surgery technique, namely, dual-port trans-subclavian thyroid endoscopic surgery) and a control group (150 cases undergoing traditional open thyroid surgery) according to their treatment intention. Laboratory and medical data from specified follow-up points are collected, and adverse events are recorded detailly.\n\nThe primary efficacy endpoint is a comparison of surgical complications between the two treatment groups. Secondary endpoints include: (1) levels of IL-2, IL-4, IL-6, IL-10, TNF-α, INF-γ, renin, angiotensin II, and aldosterone preoperatively and on the second day postoperatively; (2) NRS scores on the first day postoperatively; (3) length of hospital stay, duration of surgery, total treatment cost, and postoperative drainage volume; and (4) assessment of wound satisfaction during a three-month follow-up visit.\n\nSafety assessments include adverse events, vital signs, and pathological examinations.",[120,26],"Thyroid Neoplasms","2024-12-29",{"date":123,"type":34},"2024-12-31",{"date":125,"type":34},"2022-09-01",{"date":38,"type":20},{"name":128,"class":41},"First Affiliated Hospital of Wenzhou Medical University",{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":4,"eligibilityCriteria":135,"healthyVolunteers":11,"sex":87,"minAge":136,"maxAge":137,"enrollmentInfo":138,"targetDuration":140,"studyType":22,"phases":4,"briefSummary":141,"conditions":142,"keywords":144,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":151,"completionDateStruct":153,"leadSponsor":155,"locationsCount":78},"100561666","single-port-endoscopic-breast-conserving-surgery-100561666","NCT06593132","Single Port Endoscopic Breast Conserving Surgery","Prospective Clinical Study of Single Port Endoscopic Breast Conserving Surgery or Open Breast Conserving Surgery for Early Breast Cancer","Inclusion Criteria:\n\n1. Breast cancer confirmed by pathology；\n2. Tumor \\\u003C5 cm, TNM stage 0-II；\n3. Single Port Endoscopic or traditional open surgery; (4)20 to 70 years old female patients.\n\nExclusion Criteria:\n\n1. Bilateral breast cancer;\n2. Reconstruction after breast conserving surgery ;\n3. Basic information is not complete；\n4. Breast conserving surgery was converted to modified radical resection or subcutaneous adenoidectomy.","20 Years","70 Years",{"count":139,"type":20},200,"6 Months","The center plans to carry out a prospective clinical study of single hole total endoscopic breast conserving surgery for early breast cancer compared with open breast conserving surgery, to provide high-level evidence-based medical evidence for the development of endoscopic breast conserving surgery for early breast cancer.",[143,26],"Breast Conserving Surgery",[145,146,147],"breast conserving surgery","single port endoscopic","early breast cancer","2024-09-10",{"date":150,"type":34},"2024-09-19",{"date":152,"type":34},"2023-01-01",{"date":154,"type":20},"2025-06",{"name":156,"class":41},"Ren,Yu",{"id":158,"slug":159,"hasResults":11,"nctId":160,"briefTitle":161,"officialTitle":162,"acronym":4,"eligibilityCriteria":163,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":137,"enrollmentInfo":164,"targetDuration":4,"studyType":52,"phases":166,"briefSummary":167,"conditions":168,"keywords":4,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":181},"100312901","endoscopic-nasopharyngectomy-for-newly-diagnosed-stage-i-nasopharyngeal-carcinoma-patients-100312901","NCT03353467","Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients","A Prospective Clinical Trial of Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients","Inclusion Criteria:\n\n* Previously untreated, biopsy-proven World Health Organization (WHO) types II or III NPC; Stage I disease (American Joint Committee on Cancer 7th edition); Between 18 and 70 years old; Adequate bone marrow, liver and renal function; Satisfactory performance status: a score of 0 or 1 using the Eastern Cooperative Oncology Group System; Patients provided signed informed consent.\n\nExclusion Criteria:\n\n* Evidence of relapse or distant metastasis; History of prior malignancy or previous treatment for NPC; The presence of uncontrolled life-threatening diseases; The investigator considered the patient unable to complete the study.",{"count":165,"type":20},228,[54],"Nasopharyngeal carcinoma (NPC) is most prevalent in eastern Asia, with the highest incidence reported among the Cantonese population from the province of Guangdong. Radiotherapy is the cornerstone of initial treatment due to the radiosensitive behavior of NPC and its deep-seated location. Although radiotherapy has achieved satisfactory results, it can also cause some severe adverse events. Currently, surgery is only applied to the treatment of recurrent NPC (rNPC) patients, mainly dominated by the conventional open surgery. However, the traditional surgery was accompanied by high rate of treatment-induced complications and low rate of block removal, which greatly limited the surgical application to the treatment of primary NPC.\n\nWith the continuous improvement in surgical techniques, especially the electronic endoscopic system to be used in the surgical treatment recently, endoscopic nasopharyngectomy can largely overcome these shortcomings of traditional surgery mentioned above.\n\nIn addition, the investigators retrospectively analyzed the survival outcomes of 9 patients with NPC (all T1N0M0 according to the UICC \u002F AJCC seventh staging) treated with endoscopic nasopharyngectomy in our hospital, with 5-year rate of overall survival, loco-regional-free survival, distant metastasis-free survival of 100%. Therefore, the investigators considered endoscopic nasopharyngectomy for staged I NPC patients feasible.\n\nThis study will focus on the survival outcomes and quality of life of the staged I NPC patients treated with endoscopic nasopharyngectomy.",[169,26,170,171],"Nasopharyngeal Carcinoma","Primary Napharyngeal Carcinama","Stage I Nasopharyngeal Cancer","2021-05-31",{"date":174,"type":34},"2021-06-03",{"date":176,"type":34},"2017-10-01",{"date":178,"type":20},"2028-10-01",{"name":180,"class":41},"Sun Yat-sen University",5]